|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EIF2D-MARC2 (FusionGDB2 ID:25702) |
Fusion Gene Summary for EIF2D-MARC2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EIF2D-MARC2 | Fusion gene ID: 25702 | Hgene | Tgene | Gene symbol | EIF2D | MARC2 | Gene ID | 1939 | 54996 |
| Gene name | eukaryotic translation initiation factor 2D | mitochondrial amidoxime reducing component 2 | |
| Synonyms | HCA56|LGTN | MARC2|MOSC2 | |
| Cytomap | 1q32.1 | 1q41 | |
| Type of gene | protein-coding | protein-coding | |
| Description | eukaryotic translation initiation factor 2Dhepatocellular carcinoma-associated antigen 56ligatin | mitochondrial amidoxime reducing component 2MOCO sulphurase C-terminal domain containing 2MOSC domain-containing protein 2, mitochondrialmoco sulfurase C-terminal domain-containing protein 2molybdenum cofactor sulfurase C-terminal domain-containing pr | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P41214 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000472709, ENST00000367114, ENST00000271764, | ENST00000359316, ENST00000366913, ENST00000472447, | |
| Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 1 X 1 X 1=1 |
| # samples | 4 | 1 | |
| ** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: EIF2D [Title/Abstract] AND MARC2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | EIF2D(206778752)-MARC2(220957260), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | EIF2D | GO:0001731 | formation of translation preinitiation complex | 20713520 |
| Hgene | EIF2D | GO:0032790 | ribosome disassembly | 20713520 |
| Hgene | EIF2D | GO:0075522 | IRES-dependent viral translational initiation | 20713520 |
| Tgene | MARC2 | GO:0042126 | nitrate metabolic process | 20861021 |
| Tgene | MARC2 | GO:0055114 | oxidation-reduction process | 20861021 |
| Fusion gene breakpoints across EIF2D (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across MARC2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | 61N | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
Top |
Fusion Gene ORF analysis for EIF2D-MARC2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000472709 | ENST00000359316 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| intron-3UTR | ENST00000472709 | ENST00000366913 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| intron-3UTR | ENST00000472709 | ENST00000472447 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| In-frame | ENST00000367114 | ENST00000359316 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| 5CDS-3UTR | ENST00000367114 | ENST00000366913 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| 5CDS-3UTR | ENST00000367114 | ENST00000472447 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| In-frame | ENST00000271764 | ENST00000359316 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| 5CDS-3UTR | ENST00000271764 | ENST00000366913 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| 5CDS-3UTR | ENST00000271764 | ENST00000472447 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000367114 | EIF2D | chr1 | 206778752 | - | ENST00000359316 | MARC2 | chr1 | 220957260 | + | 969 | 647 | 21 | 674 | 217 |
| ENST00000271764 | EIF2D | chr1 | 206778752 | - | ENST00000359316 | MARC2 | chr1 | 220957260 | + | 1061 | 739 | 17 | 766 | 249 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000367114 | ENST00000359316 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + | 0.002499247 | 0.9975007 |
| ENST00000271764 | ENST00000359316 | EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + | 0.001777239 | 0.99822277 |
Top |
Fusion Genomic Features for EIF2D-MARC2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + | 0.000172658 | 0.9998273 |
| EIF2D | chr1 | 206778752 | - | MARC2 | chr1 | 220957260 | + | 0.000172658 | 0.9998273 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EIF2D-MARC2 |
| Go to FGviewer for the breakpoints of chr1:206778752-chr1:220957260 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| EIF2D | . |
| FUNCTION: Translation initiation factor that is able to deliver tRNA to the P-site of the eukaryotic ribosome in a GTP-independent manner. The binding of Met-tRNA(I) occurs after the AUG codon finds its position in the P-site of 40S ribosomes, the situation that takes place during initiation complex formation on some specific RNAs. Its activity in tRNA binding with 40S subunits does not require the presence of the aminoacyl moiety. Possesses the unique ability to deliver non-Met (elongator) tRNAs into the P-site of the 40S subunit. In addition to its role in initiation, can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. {ECO:0000269|PubMed:20566627, ECO:0000269|PubMed:20713520}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | EIF2D | chr1:206778752 | chr1:220957260 | ENST00000271764 | - | 5 | 15 | 93_173 | 176.66666666666666 | 585.0 | Domain | PUA |
| Hgene | EIF2D | chr1:206778752 | chr1:220957260 | ENST00000367114 | - | 5 | 13 | 93_173 | 176.66666666666666 | 461.0 | Domain | PUA |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | EIF2D | chr1:206778752 | chr1:220957260 | ENST00000271764 | - | 5 | 15 | 383_467 | 176.66666666666666 | 585.0 | Domain | SWIB/MDM2 |
| Hgene | EIF2D | chr1:206778752 | chr1:220957260 | ENST00000271764 | - | 5 | 15 | 491_564 | 176.66666666666666 | 585.0 | Domain | SUI1 |
| Hgene | EIF2D | chr1:206778752 | chr1:220957260 | ENST00000367114 | - | 5 | 13 | 383_467 | 176.66666666666666 | 461.0 | Domain | SWIB/MDM2 |
| Hgene | EIF2D | chr1:206778752 | chr1:220957260 | ENST00000367114 | - | 5 | 13 | 491_564 | 176.66666666666666 | 461.0 | Domain | SUI1 |
| Tgene | MARC2 | chr1:206778752 | chr1:220957260 | ENST00000359316 | 3 | 5 | 188_334 | 250.0 | 258.0 | Domain | MOSC | |
| Tgene | MARC2 | chr1:206778752 | chr1:220957260 | ENST00000366913 | 6 | 8 | 188_334 | 346.3333333333333 | 476.0 | Domain | MOSC |
Top |
Fusion Gene Sequence for EIF2D-MARC2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000367114_ENST00000359316_61N_EIF2D_chr1_206778752_-_MARC2_chr1_220957260_length(transcript)=969nt_BP=647nt CGCGGCCGGGCCCCAGCATGGCTGCCCCCACGGCTGAGGGCCTGGCAGCTGCTGCGCCCTCGCTTTCTTGACATTCCCTGGCTTCTGTGC TCTCTTCCCCAGGCCACCCCAGCAGACATGTTTGCCAAGGCCTTTCGGGTCAAGTCCAACACGGCCATCAAGGGGTCGGACAGGAGAAAG CTTCGAGCTGATGTGACAACTGCTTTCCCCACCCTTGGAACTGATCAAGTCTCTGAGTTAGTACCTGGAAAGGAGGAGCTCAACATTGTG AAGTTGTATGCTCACAAAGGGGATGCAGTGACTGTGTACGTGAGTGGTGGTAACCCCATCCTCTTTGAACTGGAGAAAAATCTGTATCCA ACAGTGTACACGCTGTGGTCCTATCCTGATCTTCTGCCAACCTTTACAACATGGCCTCTGGTGCTCGAGAAACTGGTAGGGGGAGCAGAT TTGATGCTGCCTGGACTGGTGATGCCCCCTGCTGGTCTGCCTCAGGTACAGAAGGGCGACCTCTGTGCCATTTCTTTGGTGGGGAACAGA GCCCCTGTAGCCATTGGAGTTGCAGCCATGTCCACAGCTGAGATGCTCACGTCAGGCCTGAAGGGAAGGGGCTTCTCTGTGCTCCACACT TACCAGGACCACTTGTGGCTTCAGCAACCAGGAGGGATTGACTGAGATCTTAACAACAGCAGCAACGATACATCAGCAAATCCTTATTAT CCAGCCTTCAACTATCTTTACCCTGGAAAACAATCTCGATTTTTGACTTTTCAAAGTTGTGTATGCTCCAGGTTAATGCAAGGAAAGTAT TAGAGGGGGGAATATGAAAGTATATATATAAATTTTAGGTACTGAAGGCTTTAAAAATAATTAAGATCATCAAAAATGCTATTTTGAATG >In-frame_ENST00000367114_ENST00000359316_61N_EIF2D_chr1_206778752_-_MARC2_chr1_220957260_length(amino acids)=217AA_start in transcript=21_stop in transcript=674 MPPRLRAWQLLRPRFLDIPWLLCSLPQATPADMFAKAFRVKSNTAIKGSDRRKLRADVTTAFPTLGTDQVSELVPGKEELNIVKLYAHKG DAVTVYVSGGNPILFELEKNLYPTVYTLWSYPDLLPTFTTWPLVLEKLVGGADLMLPGLVMPPAGLPQVQKGDLCAISLVGNRAPVAIGV -------------------------------------------------------------- >In-frame_ENST00000271764_ENST00000359316_61N_EIF2D_chr1_206778752_-_MARC2_chr1_220957260_length(transcript)=1061nt_BP=739nt AGTTCCAGGTACCGCCACTGGGGGCGGCCGCGGCCTCCCCAGCGGCAACGGCCACGAAGCTGCGCGGCCCTGGTTTCCAGCCGGGCCCTT TTCGCGGCCGGGCCCCAGCATGGCTGCCCCCACGGCTGAGGGCCTGGCAGCTGCTGCGCCCTCGCTTTCTTGACATTCCCTGGCTTCTGT GCTCTCTTCCCCAGGCCACCCCAGCAGACATGTTTGCCAAGGCCTTTCGGGTCAAGTCCAACACGGCCATCAAGGGGTCGGACAGGAGAA AGCTTCGAGCTGATGTGACAACTGCTTTCCCCACCCTTGGAACTGATCAAGTCTCTGAGTTAGTACCTGGAAAGGAGGAGCTCAACATTG TGAAGTTGTATGCTCACAAAGGGGATGCAGTGACTGTGTACGTGAGTGGTGGTAACCCCATCCTCTTTGAACTGGAGAAAAATCTGTATC CAACAGTGTACACGCTGTGGTCCTATCCTGATCTTCTGCCAACCTTTACAACATGGCCTCTGGTGCTCGAGAAACTGGTAGGGGGAGCAG ATTTGATGCTGCCTGGACTGGTGATGCCCCCTGCTGGTCTGCCTCAGGTACAGAAGGGCGACCTCTGTGCCATTTCTTTGGTGGGGAACA GAGCCCCTGTAGCCATTGGAGTTGCAGCCATGTCCACAGCTGAGATGCTCACGTCAGGCCTGAAGGGAAGGGGCTTCTCTGTGCTCCACA CTTACCAGGACCACTTGTGGCTTCAGCAACCAGGAGGGATTGACTGAGATCTTAACAACAGCAGCAACGATACATCAGCAAATCCTTATT ATCCAGCCTTCAACTATCTTTACCCTGGAAAACAATCTCGATTTTTGACTTTTCAAAGTTGTGTATGCTCCAGGTTAATGCAAGGAAAGT ATTAGAGGGGGGAATATGAAAGTATATATATAAATTTTAGGTACTGAAGGCTTTAAAAATAATTAAGATCATCAAAAATGCTATTTTGAA >In-frame_ENST00000271764_ENST00000359316_61N_EIF2D_chr1_206778752_-_MARC2_chr1_220957260_length(amino acids)=249AA_start in transcript=17_stop in transcript=766 MGAAAASPAATATKLRGPGFQPGPFRGRAPAWLPPRLRAWQLLRPRFLDIPWLLCSLPQATPADMFAKAFRVKSNTAIKGSDRRKLRADV TTAFPTLGTDQVSELVPGKEELNIVKLYAHKGDAVTVYVSGGNPILFELEKNLYPTVYTLWSYPDLLPTFTTWPLVLEKLVGGADLMLPG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EIF2D-MARC2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF2D-MARC2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF2D-MARC2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies